TOKYO and CAMBRIDGE, Mass., Apr 1, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that Eisai submitted to the U.S. Food andDrug Administration (FDA) a Supplemental Biologics License Application (sBLA) for monthly lecanemab-irอ่านต่อไป

Mitsubishi Heavy Industries, Ltd. (MHI) has concluded a Positive Impact Finance(1) agreement with Sumitomo Mitsui Trust Bank, Limited (SuMi TRUST Bank) (contract amount: JPY 10.0 billion yen). MHI Group, in response to the growing need to address the global challenge of climate cอ่านต่อไป